-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Maintains Overweight on Revolution Medicines, Raises Price Target to $222

Benzinga·11/05/2026 16:58:29
Listen to the news
Piper Sandler analyst Kelsey Goodwin maintains Revolution Medicines (NASDAQ:RVMD) with a Overweight and raises the price target from $210 to $222.